RB1 and cancer: Palbociclib administration delayed the progression of transplanted tumor through stimulating cancer cell senescence via strongly suppressing the phosphorylation of RB protein and subsequently down-regulating E2F-targeted genes, but did not have any effects on the apoptosis [45].